RE:RE:RE:RE:RE:RE:New Press Release - Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 MillionAgreed.
So why pop the stock price by selling 8000 TauRx shares when the investor can simply buy $1.36M of Dundee stock?
Now regular shareholders who value TauRx have 8000 less and NCIB costs 15% more?!?!